Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relistor for tube feeding tolerance in opiate-treated patients
NCT01360372Phase 3Withdrawn
- Sponsor
- Drexel University
- Start
- Oct 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylnaltrexone in Opioid-induced gastrointestinal dysfunction (OIBD), sponsored by Drexel University. Planned start Oct 2010; status: withdrawn.
02
Drugs
methylnaltrexone
03
Conditions
Opioid-induced gastrointestinal dysfunction (OIBD)
Beyond the preview
Go deeper on NCT01360372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01360372.